In this study, we mapped the peripheral blood-derived PBMCs transcriptional landscape of anti-PD-1/PD-L1 responsive and non-responsive patients with NSCLC by scRNA-seq analysis. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.